Marshall Wace, LLP Enanta Pharmaceuticals Inc Transaction History

Marshall Wace, LLP

  • $78.4 Billion
  • Q4 2024

A detailed history of Marshall Wace, LLP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 930,087 shares of ENTA stock, worth $7.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
930,087
Previous 850,890 9.31%
Holding current value
$7.47 Million
Previous $8.82 Million 39.39%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$5.75 - $12.99 $455,382 - $1.03 Million
79,197 Added 9.31%
930,087 $5.35 Million
Q3 2024

Nov 14, 2024
SELL
$10.05 - $16.54 $778,603 - $1.28 Million
-77,473 Reduced 8.35%
850,890 $8.82 Million
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $259,449 - $386,336
-22,699 Reduced 2.39%
928,363 $12 Million
Q1 2024

May 15, 2024
BUY
$10.08 - $17.46 $9.59 Million - $16.6 Million
951,062 New
951,062 $16.6 Million
Q3 2023

Nov 14, 2023
BUY
$11.09 - $22.13 $829,642 - $1.66 Million
74,810 New
74,810 $835,000
Q2 2022

Aug 15, 2022
BUY
$38.13 - $76.93 $1.91 Million - $3.86 Million
50,160 New
50,160 $2.37 Million
Q1 2022

May 16, 2022
SELL
$56.06 - $74.11 $542,100 - $716,643
-9,670 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$60.19 - $97.37 $582,037 - $941,567
9,670 New
9,670 $723,000
Q1 2021

May 17, 2021
SELL
$41.69 - $54.95 $414,898 - $546,862
-9,952 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$41.16 - $47.47 $1.03 Million - $1.19 Million
-24,982 Reduced 71.51%
9,952 $419,000
Q3 2020

Nov 16, 2020
SELL
$43.36 - $53.53 $4.2 Million - $5.19 Million
-96,890 Reduced 73.5%
34,934 $1.6 Million
Q2 2020

Aug 13, 2020
SELL
$46.37 - $57.58 $5.57 Million - $6.92 Million
-120,137 Reduced 47.68%
131,824 $6.62 Million
Q1 2020

May 15, 2020
BUY
$40.22 - $62.0 $2.85 Million - $4.4 Million
70,906 Added 39.16%
251,961 $13 Million
Q4 2019

Feb 14, 2020
BUY
$57.95 - $66.61 $503,121 - $578,308
8,682 Added 5.04%
181,055 $11.2 Million
Q3 2019

Nov 14, 2019
BUY
$60.08 - $88.17 $1.12 Million - $1.64 Million
18,587 Added 12.09%
172,373 $10.4 Million
Q2 2019

Aug 14, 2019
BUY
$81.3 - $97.35 $758,772 - $908,567
9,333 Added 6.46%
153,786 $13 Million
Q1 2019

May 14, 2019
SELL
$69.08 - $105.66 $513,817 - $785,899
-7,438 Reduced 4.9%
144,453 $13.8 Million
Q4 2018

Feb 14, 2019
BUY
$65.41 - $84.65 $7.36 Million - $9.52 Million
112,519 Added 285.78%
151,891 $10.8 Million
Q3 2018

Nov 14, 2018
BUY
$85.46 - $126.37 $3.36 Million - $4.98 Million
39,372 New
39,372 $3.37 Million

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
19.7M
Call Options Held
9.7K
Put Options Held
12.4K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $166M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email